Our gene therapies are designed to halt or reverse progression of lysosomal disorders with a single infusion. Learn about us, our focus and technology, sign up for updates, and read articles to expand your gene therapy knowledge.
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $85M
Founded date: 2015
Founders name: Chris Mason
Founders Related Locations: United States, Massachusetts, Cambridge; United States, Pennsylvania, Pittsburgh; United Kingdom, England, London; United States, District of Columbia, Washington
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.02.2018 | Series B | $60M | - |
| 02.08.2016 | Series A | $25M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Chris | Mason | Founder &a... | linkedin.c... | - | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 29.05.2018 | Top tech startup news stories you need to know this Tuesday,... | Good morning! Here are some of the top tech startup news stories for today, Tuesday, May 29. Invest... | techstartu... |
| 05.02.2018 | Capitalizing on a gene therapy boom, Avrobio locks in $60M | Announced Thursday, the raise was co-led by Cormorant Asset Management and Surveyor Capital, with su... | medcitynew... |
| 02.02.2018 | Term Sheet — Friday, February 2 | IPO DELAYS Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From E... | fortune.co... |
| 01.02.2018 | AVROBIO, Inc. Announces $60 Million Series B Financing to Ad... | Company to initiate Phase 2 trial with lead gene therapy, AVR RD 01, based on promising initial clin... | svhealthin... |
| 01.02.2018 | AVROBIO, Inc. Announces $60 Million Series B Financing to Ad... | CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc., a clinical-stage biotechnology company developing tr... | aislingcap... |
| 01.02.2018 | AVROBIO Receives $60M Series B Funding | CAMBRIDGE, MA, AVROBIO announced today that it has completed a $60 million Series B financing. &g... | vcnewsdail... |
| 01.02.2018 | Avrobio Raises $60M in Series B Financing | Avrobio, a Cambridge, Mass.-based clinical-stage biotechnology company developing gene therapies for... | finsmes.co... |
| 01.02.2018 | AVROBIO Raises $60M In Series B | AVROBIO, Inc., a clinical-stage biotechnology company developing transformative, life-changing gene ... | citybizlis... |
| 01.02.2018 | Avrobio pulls in $60M to push Fabry, Gaucher candidates thro... | Avrobio has raised $60 million in series B financing to “aggressively” advance its gene therapy pipe... | fiercebiot... |
| 02.08.2016 | Avrobio Raises $25M in Series A Financing | Avrobio, Inc., a Cambridge, MA-based clinical-stage biotechnology company developing gene therapies ... | finsmes.co... |
Show more